Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
1.
Prenat Diagn ; 40(11): 1353-1365, 2020 10.
Artículo en Inglés | MEDLINE | ID: mdl-32125721

RESUMEN

Prenatal diagnosis of sex discordance is a relatively new phenomenon. Prior to cell-free DNA testing, the diagnosis of a disorder of sexual differentiation was serendipitous, either through identification of ambiguous genitalia at the midtrimester morphology ultrasound or discovery of genotype-phenotype discordance in cases where preimplantation genetic diagnosis or invasive prenatal testing had occurred. The widespread integration of cfDNA testing into modern antenatal screening has made sex chromosome assessment possible from 10 weeks of gestation, and discordant fetal sex is now more commonly diagnosed prenatally, with a prevalence of approximately 1 in 1500-2000 pregnancies. Early detection of phenotype-genotype sex discordance is important as it may indicate an underlying genetic, chromosomal or biochemical condition and it also allows for time-critical postnatal treatment. The aim of this article is to review cfDNA and ultrasound diagnosis of fetal sex, identify possible causes of phenotype-genotype discordance and provide a systematic approach for clinicians when counseling and managing couples in this circumstance.


Asunto(s)
Trastornos del Desarrollo Sexual/diagnóstico , Pruebas Prenatales no Invasivas , Análisis para Determinación del Sexo , Ultrasonografía Prenatal , Ácidos Nucleicos Libres de Células/análisis , Femenino , Genotipo , Humanos , Fenotipo , Embarazo , Procesos de Determinación del Sexo
2.
Prenat Diagn ; 40(11): 1466-1473, 2020 10.
Artículo en Inglés | MEDLINE | ID: mdl-32673423

RESUMEN

OBJECTIVE: The accuracy of cell-free DNA aneuploidy screening varies by the chromosome assessed. The positive predictive value is consistently low for monosomy X (MX), at less than 30%. This study aims to investigate maternal age and other possible predictors of false-positive MX screening results in order to guide pre-test and post-test counselling. METHODS: A total of 52 499 NIPT samples were tested over 69 months, across three specialist obstetric services. Outcome data were available for 96 out of 107 cases high risk for MX. Cytogenetic outcomes were compared to clinical and demographic data to look for trends that may indicate higher likelihood of a false-positive NIPT result. RESULTS: The likelihood of a false-positive MX result significantly increased with the absence of ultrasound features suggestive of MX and with lower PAPP-A levels. Non-significant trends towards false-positive results were identified with increased maternal age, increased body mass index and Caucasian ethnicity. CONCLUSION: Maternal age is not a reliable predictor of a false-positive result. Assessment of ultrasound findings and placental serology in the first trimester is important for appropriate post-test counselling and should continue to be a part of screening even when NIPT is used as a first-tier screening test.


Asunto(s)
Edad Materna , Pruebas Prenatales no Invasivas/estadística & datos numéricos , Síndrome de Turner/diagnóstico , Adulto , Reacciones Falso Positivas , Femenino , Humanos , Embarazo , Estudios Retrospectivos
3.
Prenat Diagn ; 37(13): 1298-1304, 2017 12.
Artículo en Inglés | MEDLINE | ID: mdl-29131362

RESUMEN

OBJECTIVE: The objectives of this study were to characterise genotype-phenotype discordance identified in the routine clinical setting and to explore the associated diagnostic and counselling challenges. METHOD: Cases were derived from a cohort of pregnant women who attended a multisite specialist prenatal screening and ultrasound service for non-invasive prenatal testing by cell-free DNA analysis and midtrimester fetal morphology assessment. RESULTS: Seven cases of genotype-phenotype discordance were identified from a cohort of 12 919 women between June 2013 and March 2017 (incidence 1/1845 pregnancies). A variety of disorders of sexual differentiation were subsequently diagnosed. CONCLUSION: Sex chromosomes are the basis of sexual differentiation during embryonic development. Variations of the traditional XX or XY karyotype may result in conditions where the genotype is discordant with the phenotype. Detection of these conditions in the past typically occurred during adolescence, due to delayed puberty, or during adulthood, due to infertility. With the increasing availability of non-invasive prenatal testing and high-resolution ultrasound, more cases of genotype-phenotype sex discordance are being identified in routine clinical practice during early pregnancy. These discordant results present significant diagnostic and counselling challenges, and their potential should be included in increasingly complex pre-NIPT counselling.


Asunto(s)
Pruebas de Detección del Suero Materno , Trastornos de los Cromosomas Sexuales del Desarrollo Sexual/diagnóstico , Adulto , Síndrome de Resistencia Androgénica/diagnóstico , Deleción Cromosómica , Cromosomas Humanos Par 9 , Femenino , Humanos , Masculino , Embarazo , Translocación Genética
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA